2 weeks Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q3 2024 Earnings Call TranscriptInsider Monkey

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q3 2024 Earnings Call Transcript November 8, 2024 Y-mAbs Therapeutics, Inc. reports earnings inline with expectations. Reported EPS is $-0.16 EPS, expectations were $-0.16. Operator: Good morning, and welcome to Y-mAbs Therapeutics Inc. Third Quarter Conference Call for 2024. At this time, all participants are in a listen-only mode. Instruction for […]

·